Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.30%6.47B | -10.21%13.87B | -8.41%7.05B | 0.42%15.44B | 1.03%7.7B | 9.22%15.38B | 21.97%7.62B | 40.43%14.08B | 56.12%6.25B | 95.54%10.03B |
| Operating income | -8.30%6.47B | -10.21%13.87B | -8.41%7.05B | 0.42%15.44B | 1.03%7.7B | 9.22%15.38B | 21.97%7.62B | 40.43%14.08B | 56.12%6.25B | 95.54%10.03B |
| Cost of sales | 5.67%-5.53B | 7.93%-11.78B | 4.35%-5.86B | -6.70%-12.8B | -10.02%-6.12B | -17.46%-11.99B | -27.30%-5.57B | -44.78%-10.21B | -60.41%-4.37B | -117.39%-7.05B |
| Operating expenses | 5.67%-5.53B | 7.93%-11.78B | 4.35%-5.86B | -6.70%-12.8B | -10.02%-6.12B | -17.46%-11.99B | -27.30%-5.57B | -44.78%-10.21B | -60.41%-4.37B | -117.39%-7.05B |
| Gross profit | -21.23%939.27M | -21.22%2.08B | -24.22%1.19B | -21.82%2.65B | -23.34%1.57B | -12.53%3.38B | 9.54%2.05B | 30.13%3.87B | 46.93%1.87B | 57.90%2.97B |
| Selling expenses | 33.83%-15.62M | 58.94%-41.62M | 55.24%-23.6M | -8.49%-101.38M | -79.25%-52.73M | 34.02%-93.45M | 52.30%-29.42M | -83.61%-141.64M | -112.70%-61.66M | -78.96%-77.14M |
| Administrative expenses | 19.35%-275.18M | 5.25%-792.55M | 10.96%-341.18M | 1.79%-836.42M | 3.91%-383.17M | -9.45%-851.67M | -3.64%-398.74M | -41.92%-778.13M | -74.04%-384.72M | -85.88%-548.3M |
| Impairment and provision | 96.38%-104.36M | -376.80%-4.61B | -6,223.59%-2.88B | -107.77%-967.43M | 83.39%-45.61M | -190.69%-465.62M | -579.56%-274.51M | -64.45%-160.18M | -95.35%-40.4M | -696.06%-97.41M |
| -Goodwill impairment | ---- | 42.46%-246.21M | ---- | ---427.89M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 96.38%-104.36M | -709.30%-4.37B | -6,223.59%-2.88B | -15.87%-539.54M | 83.39%-45.61M | -190.69%-465.62M | -579.56%-274.51M | -64.45%-160.18M | -95.35%-40.4M | -696.06%-97.41M |
| Special items of operating profit | 371.66%43.03M | -146.15%-130.79M | -91.96%9.12M | -35.72%283.41M | 30.20%113.4M | 57.38%440.88M | -35.52%87.1M | 29.90%280.13M | 0.13%135.09M | 38.58%215.65M |
| Operating profit | 128.68%587.14M | -441.24%-3.49B | -269.82%-2.05B | -57.59%1.02B | -16.12%1.21B | -21.34%2.41B | -5.59%1.44B | 24.46%3.07B | 33.58%1.52B | 46.07%2.47B |
| Financing cost | 13.60%-17.07M | -43.24%-28.83M | -70.42%-19.76M | -8.42%-20.13M | -21.57%-11.59M | 25.41%-18.57M | 21.27%-9.54M | 38.33%-24.89M | 40.79%-12.11M | -146.87%-40.36M |
| Share of profit from joint venture company | 6.05%20.66M | -60.65%17.68M | 73.25%19.48M | -20.31%44.94M | -62.28%11.24M | 78.83%56.39M | -10.40%29.81M | -49.35%31.53M | 51.40%33.27M | 175.07%62.26M |
| Earning before tax | 128.85%590.73M | -434.23%-3.5B | -269.89%-2.05B | -57.24%1.05B | -17.31%1.21B | -20.28%2.45B | -5.57%1.46B | 23.63%3.08B | 35.26%1.54B | 46.82%2.49B |
| Tax | -128.33%-142.49M | 207.97%377.7M | 298.34%503M | 32.34%-349.81M | 17.62%-253.6M | -1.38%-517.02M | -17.34%-307.83M | 0.97%-510.01M | 2.07%-262.33M | -27.84%-515.02M |
| After-tax profit from continuing operations | 129.02%448.23M | -547.51%-3.13B | -262.31%-1.54B | -63.89%698.73M | -17.22%951.51M | -24.58%1.93B | -10.27%1.15B | 30.05%2.57B | 46.71%1.28B | 52.74%1.97B |
| Earning after tax | 129.02%448.23M | -547.51%-3.13B | -262.31%-1.54B | -63.89%698.73M | -17.22%951.51M | -24.58%1.93B | -10.27%1.15B | 30.05%2.57B | 46.71%1.28B | 52.74%1.97B |
| Minority profit | -3.85%97.94M | -39.54%143.81M | -9.50%101.86M | 149.51%237.86M | 22.89%112.55M | -62.92%95.33M | -33.97%91.59M | 17.77%257.11M | 20.38%138.71M | 258.94%218.32M |
| Profit attributable to shareholders | 121.28%350.3M | -809.67%-3.27B | -296.23%-1.65B | -74.95%460.88M | -20.70%838.95M | -20.31%1.84B | -7.39%1.06B | 31.58%2.31B | 50.71%1.14B | 42.55%1.75B |
| Basic earnings per share | 121.55%0.25 | -818.75%-2.3 | -296.61%-1.16 | -75.38%0.32 | -21.33%0.59 | -22.16%1.3 | -11.76%0.75 | 26.52%1.67 | 49.12%0.85 | 43.48%1.32 |
| Diluted earnings per share | 121.55%0.25 | -818.75%-2.3 | -296.61%-1.16 | -75.38%0.32 | -21.33%0.59 | -22.16%1.3 | -11.76%0.75 | 26.52%1.67 | 49.12%0.85 | 43.48%1.32 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Zhitong (Hong Kong) Certified Public Accountants Limited | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.